Bay Area Lyme Foundation
Overview
Bay Area Lyme Foundation is a national nonprofit organization and public charity that provides philanthropic capital and research support to accelerate medical breakthroughs for Lyme disease.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Flightpath Biosciences, Inc. | Oct 2024 | Series A | Co-investor |
| Ceres Nanosciences, Inc. | May 2018 | Series A Extension | Co-investor |
| LymeAlert | Sep 2025 | VC Round | Co-investor |
| ACES Diagnostics | May 2026 | Seed Round | Co-investor |
| Galaxy Diagnostics, Inc. | May 2026 | Strategic | Lead |
Key People
Laure L. Woods
Co-Founder And Co-Chair
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bay Area Lyme Foundation based?
Bay Area Lyme Foundation is headquartered in Portola Valley, California, United States.
When was Bay Area Lyme Foundation founded?
Bay Area Lyme Foundation was founded in 2011.
How many portfolio companies does Bay Area Lyme Foundation have?
Bay Area Lyme Foundation has 5 portfolio companies in Caplight's dataset.
What are some companies in Bay Area Lyme Foundation's portfolio?
Portfolio companies visible on Caplight include Flightpath Biosciences, Inc., Ceres Nanosciences, Inc., LymeAlert, ACES Diagnostics, Galaxy Diagnostics, Inc..
What was Bay Area Lyme Foundation's most recent investment shown here?
Bay Area Lyme Foundation's most recent investment in this portfolio sample was in ACES Diagnostics in 2026.
What sectors does Bay Area Lyme Foundation focus on?
Bay Area Lyme Foundation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce.
What company stages does Bay Area Lyme Foundation focus on?
Bay Area Lyme Foundation typically invests at the Early stage.
What is Bay Area Lyme Foundation's AUM?
Bay Area Lyme Foundation's assets under management are estimated between $5.0M and $5.0M.